All lobbying filings
HB STRATEGIES
HB STRATEGIES filed a Q3 report for BAYER U.S. LLC on October 19, 2026, reporting $110,000 in lobbying income.
Lobbying for BAYER U.S. LLC · Pharmaceutical and life sciences company
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$110,000
What the client paid this registrant for the period.
Client based in
New Jersey
Lobbyists on this filing
2
-
ERIC LAUSTENPreviously held: Congressman Lipinski - Chief of Staff, Assistant House Science, Space &Technology Committee - Legislative Director Congressman Acevedo-Vila- Legislative Director Congressmen McKinney - Legislative Director
-
ANDREW FISHERPreviously held: FPAC/USDA, Chief of Staff Senator McConnell, Legislative Aide Senator Blunt, Legislative Aide
Government bodies contacted
2
Lobbying activity
3
Provide lobbying support on key issues and track relevant federal policy developments that could impact the pharmaceutical, healthcare industries generally and Bayer specifically.
Provide lobbying support on key issues and track relevant federal policy developments that could impact the pharmaceutical, healthcare industries generally and Bayer specifically.
Provide lobbying support on key issues and track relevant federal policy developments that could impact the pharmaceutical, healthcare industries generally and Bayer specifically.